Agile Therapeutics logo
Agile Therapeutics AGRX

Quarterly report 2024-Q2
added 08-12-2024

report update icon

Agile Therapeutics DPO Ratio 2011-2026 | AGRX

Annual DPO Ratio Agile Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
352 439 214 5.01 K - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
5.01 K 214 1.5 K

Quarterly DPO Ratio Agile Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
889 603 - 240 327 412 - 542 441 545 - 203 492 386 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
889 203 462

DPO Ratio of other stocks in the Drug manufacturers industry

Issuer DPO Ratio Price % 24h Market Cap Country
Alimera Sciences Alimera Sciences
ALIM
309 - - $ 142 M usaUSA
Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation
ADMP
345 - 0.86 % $ 117 M usaUSA
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
116 - - $ 754 M usaUSA
Canopy Growth Corporation Canopy Growth Corporation
CGC
52.8 $ 1.2 1.27 % $ 129 M canadaCanada
AcelRx Pharmaceuticals AcelRx Pharmaceuticals
ACRX
58.9 - 7.5 % $ 6.35 M usaUSA
Cronos Group Cronos Group
CRON
212 $ 2.68 -0.56 % $ 1.42 B canadaCanada
Catalent Catalent
CTLT
41.8 - - $ 11.5 B usaUSA
DURECT Corporation DURECT Corporation
DRRX
519 - - $ 50.1 M usaUSA
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
75.6 - -39.89 % $ 27.7 M usaUSA
Endo International plc Endo International plc
ENDP
39.3 - - $ 28.9 M irlandaIrlanda
Evoke Pharma Evoke Pharma
EVOK
5.36 K - - $ 36.6 M usaUSA
Emergent BioSolutions Emergent BioSolutions
EBS
55.8 $ 13.92 5.86 % $ 713 M usaUSA
Athenex Athenex
ATNX
111 - -23.39 % $ 1.76 M usaUSA
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
224 $ 21.48 -0.12 % $ 2.04 B franceFrance
Evolus Evolus
EOLS
29.4 $ 5.72 -3.3 % $ 355 M usaUSA
Harrow Health Harrow Health
HROW
189 $ 50.79 -5.07 % $ 1.66 B usaUSA
China Pharma Holdings China Pharma Holdings
CPHI
33.4 $ 1.38 9.13 % $ 24.1 M chinaChina
Jupiter Wellness Jupiter Wellness
JUPW
215 - - $ 33.6 M usaUSA
Bausch Health Companies Bausch Health Companies
BHC
78.1 $ 7.9 3.41 % $ 2.88 B canadaCanada
Lannett Company Lannett Company
LCI
36.8 - 1.15 % $ 7.11 M usaUSA
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
775 $ 5.14 8.9 % $ 72.3 M usaUSA
Organogenesis Holdings Organogenesis Holdings
ORGO
94 $ 4.32 -0.92 % $ 569 M usaUSA
Aurora Cannabis Aurora Cannabis
ACB
-807 $ 4.23 -0.25 % $ 86.3 M canadaCanada
Pacira BioSciences Pacira BioSciences
PCRX
37.3 $ 26.13 3.24 % $ 1.21 B usaUSA
PetIQ PetIQ
PETQ
54.2 - 1.64 % $ 400 M usaUSA
Recro Pharma Recro Pharma
REPH
6.63 - -4.76 % $ 65.3 M usaUSA
Perrigo Company plc Perrigo Company plc
PRGO
62.7 $ 14.7 -0.47 % $ 2.02 B usaUSA
ProPhase Labs ProPhase Labs
PRPH
45.4 - - $ 5.07 M usaUSA
Rockwell Medical Rockwell Medical
RMTI
20.9 $ 0.95 2.85 % $ 22.2 M usaUSA
Radius Health Radius Health
RDUS
274 - - $ 1.42 B usaUSA
OptiNose OptiNose
OPTN
194 - - $ 1.08 B usaUSA
Assertio Holdings Assertio Holdings
ASRT
131 $ 9.35 -1.86 % $ 664 M usaUSA
Sonoma Pharmaceuticals Sonoma Pharmaceuticals
SNOA
32.3 $ 3.8 - $ 4.72 M usaUSA
SCYNEXIS SCYNEXIS
SCYX
20.2 $ 0.64 -0.12 % $ 30.6 M usaUSA
Tilray Tilray
TLRY
53 $ 8.95 -3.35 % $ 5.53 B canadaCanada
Veru Veru
VERU
264 $ 2.34 0.43 % $ 316 M usaUSA
TherapeuticsMD TherapeuticsMD
TXMD
723 $ 2.0 -2.0 % $ 20.9 M usaUSA
Viatris Viatris
VTRS
64 $ 12.42 0.12 % $ 15.1 B usaUSA
cbdMD cbdMD
YCBD
84 $ 1.11 -3.91 % $ 4.79 M usaUSA
Zomedica Corp. Zomedica Corp.
ZOM
211 - -0.21 % $ 98 M usaUSA